{"id":588183,"date":"2022-02-24T19:54:01","date_gmt":"2022-02-24T19:54:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=588183"},"modified":"2022-02-24T19:54:01","modified_gmt":"2022-02-24T19:54:01","slug":"digital-therapeutic-device-market-is-expected-to-grow-at-a-cagr-of-27-by-2026-an-exclusive-market-research-report-by-lucintel","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/digital-therapeutic-device-market-is-expected-to-grow-at-a-cagr-of-27-by-2026-an-exclusive-market-research-report-by-lucintel_588183.html","title":{"rendered":"Digital Therapeutic Device Market is expected to grow at a CAGR of 27% by 2026- An exclusive market research report by Lucintel"},"content":{"rendered":"
\n
\"Digital<\/a><\/div>\n
\n
Trends and Forecast for the Global Digital Therapeutic Device Market<\/div>\n<\/div>\n<\/div>\n
Trends, opportunities and forecast in digital therapeutic device market to 2024 by application (preventive (prediabetes, obesity, smoking cessation, and others) and treatment\/care (diabetes, cardiovascular diseases, central nervous system diseases, respiratory diseases, and others)), end use (patients, caregivers, providers, payers, employers, pharmaceutical companies, and others), device type (respiratory therapy devices, pain management devices, insulin pumps, rehabilitation device, and others<\/div>\n

Lucintel’s latest market report analyzed that digital therapeutic device<\/a> provides attractive opportunities in preventive and treatment\/care such as obesity, diabetes, cardiovascular disease, respiratory disease, and mus culoskeletal diseases. The digital therapeutic device market is expected to grow with a CAGR of 27%. In this market, insulin pump is the largest segment by device type.<\/p>\n

Download Brochure<\/strong> of this report by clicking on https:\/\/www.lucintel.com\/digital-therapeutic-device-market.aspx<\/a>    <\/p>\n

Based on device type, the digital therapeutic device market is segmented into respiratory therapy devices, pain management devices, insulin pumps, rehabilitation device, and others. The insulin pumps segment accounted for the largest share of the market in 2020.<\/p>\n

Browse in-depth TOC on “Digital Therapeutic Device Market”<\/p>\n

XX – Tables<\/p>\n

XX – Figures<\/p>\n

150 – Pages<\/p>\n

The digital therapeutic device market is marked by the presence of several big and small players. Some of the prominent players offering digital therapeutic device include Proteus Digital Health, Omada Health, Welldoc, Livongo Health, Noom, Ginger.Io, Propeller Health, 2morrow, Canary Health, and Mango Health.  <\/p>\n

Request Sample Report:<\/strong><\/p>\n

https:\/\/www.lucintel.com\/digital-therapeutic-device-market.aspx<\/a><\/p>\n

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com<\/a>.<\/p>\n

About Lucintel<\/strong><\/p>\n

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis<\/a>, growth consulting<\/a>, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com<\/a>.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Lucintel<\/a>
Contact Person:<\/strong> Brandon Fitzgerald
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 303.775.0751
Address:<\/strong>8951 Cypress Waters Blvd., Suite 160
City:<\/strong> Dallas
State:<\/strong> TEXAS
Country:<\/strong> United States
Website:<\/strong> www.lucintel.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Trends and Forecast for the Global Digital Therapeutic Device Market Trends, opportunities and forecast in digital therapeutic device market to 2024 by application (preventive (prediabetes, obesity, smoking cessation, and others) and treatment\/care (diabetes, cardiovascular diseases, central nervous system diseases, respiratory … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,421,420,411,416],"tags":[],"class_list":["post-588183","post","type-post","status-publish","format-standard","hentry","category-Business","category-Computers-Software","category-Science","category-Technology","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/588183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=588183"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/588183\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=588183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=588183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=588183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}